The registration of medical devices is a key element of the state system ensuring the safety of medical products and protecting public health. It serves as a mechanism for admitting to the domestic market only those devices that meet established requirements of quality, efficacy, and safety. In Uzbekistan, this procedure is governed by Resolution No. 213, developed in accordance with the Law “On Medicines and Pharmaceutical Activities” and Presidential Decrees No. PP-3489 and No. PP-3532, which aim to develop the pharmaceutical industry and improve the regulation of medical product circulation.
The main executive body for registration is the State Institution “Center for Pharmaceutical Product Safety” under the Ministry of Health. The Center receives applications, conducts document reviews, and organizes laboratory tests.
Other participating bodies include:
Objects and Conditions of Registration
Registration is required for:
Exempt from registration are products intended solely for scientific research, exhibitions, or humanitarian aid.
Registration Procedure and Stages
|
Stage |
Content |
Duration |
|
1. Application submission |
Submission through the electronic system of the Center; electronic copies of registration documents, product samples, and proof of fee payment must be attached. |
— |
|
2. Preliminary examination |
Verification of completeness of documents and initial assessment of compliance with intellectual property rights (IPR). |
up to 15 days |
|
3. Laboratory testing |
Chemical-technical tests and safety analysis. |
15–120 days depending on product class |
|
4. Expert committee review |
Comprehensive evaluation and recommendations for approval or rejection. |
up to 155 days |
|
5. Certificate issuance |
Upon positive decision, the Center issues a Registration Certificate confirming the product’s authorization for medical use. |
1 working day |
The total review period does not exceed 155 days, excluding time for addressing remarks or conducting clinical trials.
Documents and Requirements
The applicant must submit:
It is prohibited to demand documents not specified in the regulation.
Financial Conditions
A state fee of 10 BCV (base calculation value) is charged for the review of the application and 2 BCV for issuance of the certificate. For foreign manufacturers, the certificate is valid for 5 years; for domestic manufacturers, it is perpetual.
Expertise and Control
The expert evaluation of medical devices assesses:
Results are formalized in an expert opinion, which forms the basis for the registration decision.
Recognition of Foreign Registrations
The regulation allows simplified registration for devices already approved in countries with high regulatory standards and/or recognized by the WHO. Such devices may be registered without repeated clinical trials, provided certification and quality confirmation are submitted.
Scientific and Practical Significance
The registration process ensures:
Registration of medical devices in Uzbekistan is a complex yet transparent mechanism for market authorization. It is based on principles of scientific justification, independent expertise, and international recognition of quality standards. Further system development requires digitalization, reduction of review timelines, and integration with international databases.
Step-by-Step Algorithm of Medical Device Registration
|
№ |
Stage |
Responsible Body |
Description |
Duration |
Result / Document |
|
1 |
Preparation of dossier |
Applicant |
Formation of a registration dossier including technical documentation, manuals, GMP/ISO certificates, and safety and efficacy data. |
— |
Complete dossier |
|
2 |
Submission of application |
Applicant → Center for Pharmaceutical Product Safety (CPPS) |
Electronic submission through CPPS system with attachments and fee payment (10 BCV). |
— |
Electronic receipt |
|
3 |
Preliminary review |
CPPS Registration Department |
Verification of dossier completeness and IPR data. |
up to 15 days |
Decision to proceed to expertise |
|
4 |
Contract and sample transfer |
CPPS ↔ Applicant |
Signing of contract for expertise; transfer of samples to laboratories. |
up to 3 days |
Payment and transfer confirmation |
|
5 |
Laboratory research |
CPPS laboratories |
Conducting chemical, biological, and toxicological tests; evaluation of compliance with standards. |
15–120 days |
Laboratory test report |
|
6 |
Document expertise |
Pharmacopoeial, Pharmacological, and New Equipment Committees |
Analysis of dossier for quality, safety, efficacy, regulatory compliance, and IPR verification. |
up to 155 days |
Expert conclusion |
|
7 |
Expert Council meeting |
Ministry of Health |
Review of committee conclusions and decision on registration or refusal. |
within 5 days after expertise |
Registration decision |
|
8 |
Certificate issuance |
CPPS |
Preparation and issuance (or electronic dispatch) of State Registration Certificate. |
1 working day |
Registration Certificate |
|
9 |
Entry into State Register |
CPPS / Ministry of Health |
Entry of data into the State Register of authorized medical devices. |
immediately after registration |
Publication in the Register |
|
10 |
Post-registration control |
CPPS / Pharminspection |
Ongoing monitoring of quality, complaints, pharmacovigilance, and changes in composition or technology. |
continuous |
Pharmacovigilance report |
Classification of Medical Devices by Risk Level and Registration Duration
|
Class |
Risk Characteristics |
Example Devices |
Main Requirements / Scope of Expertise |
Registration Time (working days) |
|
Class I (low risk) |
Minimal impact on human body; short-term or external use. |
Bandages, syringes, thermometers, gauze, disposable gloves. |
Review of technical documentation, laboratory tests (if required), ISO 13485 compliance. |
up to 15 days (simplified) |
|
Class II-a (moderate risk) |
Limited impact or short-term internal use. |
Infusion systems, catheters, contact lenses, dental materials. |
Dossier expertise, lab tests, compliance with technical regulations. |
up to 60 days |
|
Class II-b (increased risk) |
Longer or invasive use; clinical data required. |
Diagnostic reagents, endoscopes, physiotherapy devices, medium-complex implants. |
Clinical trials (≤ 90 days), toxicological and pharmacological studies. |
up to 120 days |
|
Class III (high risk) |
High impact on vital functions; invasive or implantable. |
Pacemakers, artificial heart valves, orthopedic implants, artificial organs. |
Full cycle of expertise: lab, toxicological, clinical, GMP certification, IPR review. |
up to 155 days |
Additional Provisions